SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Enanta Pharmaceuticals (ENTA)

ENTA RSS Feed
Add ENTA Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board: 
Last Post: 8/18/2017 11:01:08 AM - Followers: 63 - Board type: Free - Posts Today: 0
ENTA
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ENTA News: Quarterly Report (10-q) 08/09/2017 04:10:04 PM
ENTA News: Current Report Filing (8-k) 08/07/2017 04:16:17 PM
ENTA News: Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2017 08/07/2017 04:01:00 PM
ENTA News: Enanta Announces U.S. FDA Approval of AbbVie’s MAVYRET™ (glecaprevir/pibrentasvir) for the Treatment of Chronic Hepatitis... 08/03/2017 03:39:00 PM
ENTA News: Enanta Announces European Commission Grants AbbVie Marketing Authorization for MAVIRET® (glecaprevir/pibrentasvir) for the T... 07/28/2017 11:05:00 AM
PostSubject
#1483  Sticky Note FDA approves ABBV/ENTA’s Mavyret: #msg-133548596. DewDiligence 08/03/17 03:24:43 PM
#1487   Maviret* approved in Canada: DewDiligence 08/18/17 11:01:07 AM
#1486   Pro forma cash, diluted share count, and enterprise DewDiligence 08/09/17 06:24:34 PM
#1485   ENTA FY3Q17 CC transcript: DewDiligence 08/08/17 10:40:19 AM
#1484   ENTA reports FY3Q17 results: DewDiligence 08/07/17 04:21:49 PM
#1483   FDA approves ABBV/ENTA’s Mavyret: #msg-133548596. DewDiligence 08/03/17 03:24:43 PM
#1482   European Commission approves GILD’s Vosevi and ABBV/ENTA’s Maviret, DewDiligence 07/28/17 12:14:38 PM
#1480   FY3Q17 CC 8/7/17, 4:30pm ET: DewDiligence 07/25/17 04:43:10 PM
#1479   Vosevi’s US list price leaves ample room for DewDiligence 07/19/17 11:10:25 AM
#1478   I don't have any company-specific explanation. Note that DewDiligence 07/10/17 12:15:21 PM
#1477   Anyone care to speculate why the stock is guyschmid 07/10/17 12:12:07 PM
#1476   News for 'ENTA' - (*DJ Enanta Announces New biotech_researcher 06/26/17 08:50:18 AM
#1475   ENTA will receive an undisclosed milestone payment from DewDiligence 06/23/17 09:44:23 AM
#1474   Sweet. I'll bet Dew didn't have the nifty DaveAu 06/23/17 08:57:06 AM
#1473   Enanta Announces that AbbVie Receives CHMP Positive Opinion DaveAu 06/23/17 08:54:44 AM
#1472   ENTA’s pro forma EV is only $412M: #msg-131344710. DewDiligence 05/14/17 01:18:19 PM
#1471   Early access to G/P in UK stockbettor 05/11/17 03:53:27 PM
#1470   ENTA reports FY2Q17 financial results: DewDiligence 05/08/17 04:09:48 PM
#1469   ENTA mentioned in Reuters profile of NASH arena: #msg-130744801. DewDiligence 04/24/17 10:40:29 AM
#1468   JNJ/ACHN’s 3-DAA HCV regimen has a problem: #msg-130712374. DewDiligence 04/22/17 11:59:23 AM
#1467   Brief comments on today's PR: #msg-130606473. DewDiligence 04/19/17 11:41:21 AM
#1466   Enanta Announces New Preclinical Data on its FXR biotech_researcher 04/19/17 07:56:45 AM
#1464   It's low volume at least, but the data biotech_researcher 04/05/17 03:49:27 PM
#1463   New info showing EDP-305 superiority to Ocaliva in DewDiligence 04/05/17 10:37:11 AM
#1462   I posted the relevant text from today's PR DewDiligence 04/05/17 09:52:02 AM
#1461   Enanta Pharmaceuticals Announces Data Presentations at The International biotech_researcher 04/05/17 07:31:15 AM
#1459   ENTA presenting at Wainwright NASH conference 4/3/17, 4pm ET: DewDiligence 03/27/17 04:07:19 PM
#1458   Bullish WSJ profile on ENTA: #msg-129765873. DewDiligence 03/22/17 02:14:29 PM
#1457   ENTA's pro forma EV is only $284M: #msg-129620784. DewDiligence 03/17/17 12:12:41 PM
#1456   G/P receives priority review in Japan: DewDiligence 03/14/17 09:06:06 AM
#1455   CHMP approves 8-week duration of Viekirax/Exviera for treatment-naïve GT1b: DewDiligence 02/27/17 11:03:50 AM
#1454   ENTA slides from RBC webcast—new slide re FXR agonists: DewDiligence 02/22/17 03:03:17 PM
#1453   New ENTA slide set (from today’s Leerink webcast): DewDiligence 02/15/17 03:50:47 PM
#1452   The FY1Q17 10-Q has been filed: DewDiligence 02/09/17 05:05:35 PM
#1451   ENTA cash at 12/31/16 was $244.4M—an increase of DewDiligence 02/08/17 04:21:37 PM
#1450   ENTA webcasts at Leerink and RBC: DewDiligence 02/06/17 04:45:41 PM
#1449   FDA grants priority review for G/P regimen: #msg-128359345. DewDiligence 02/02/17 08:19:57 AM
#1448   ABBV’s 2017 Viekira sales guidance is $1.0B, implying DewDiligence 01/27/17 09:43:53 AM
#1447   4Q16 Viekira sales $311M, -18% QoQ: #msg-128193393. DewDiligence 01/27/17 09:13:07 AM
#1446   FDA priority review is almost certain given that DewDiligence 01/24/17 10:41:50 AM
#1445   I'm surprised this didn't even give the stock DaveAu 01/24/17 10:36:39 AM
#1444   EMA grants accelerated assessment for G/P HCV regimen: #msg-128090944. DewDiligence 01/24/17 10:16:03 AM
#1443   FY1Q17 CC will be 2/8/17 at 4:30pm ET: DewDiligence 01/23/17 10:24:13 AM
#1442   BlackRock upped its stake from 10.4% to 10.9% DewDiligence 01/12/17 12:54:28 PM
#1441   ENTA’s JPM slides contain new info on non-HCV pipeline: DewDiligence 01/12/17 12:17:16 PM
#1440   ENTA reports near-perfect G/P data in Japanese patients: #msg-127727429. DewDiligence 01/09/17 12:14:43 PM
#1439   Musings on discontinuation of EDP-494: #msg-127673557. DewDiligence 01/06/17 11:23:02 AM
#1438   Today's PR on 2017 news flow: DewDiligence 01/06/17 11:21:56 AM
#1437   EDP-305 for NASH gets FDA Fast Track designation: #msg-127607645. DewDiligence 01/04/17 09:17:19 AM
#1436   ENTA webcast at JPM: 1/11/17 at 12:00pm ET DewDiligence 12/26/16 11:42:15 AM
#1435   Links and context wrt G/P NDA submission: #msg-127281791. DewDiligence 12/19/16 09:03:46 AM
PostSubject